These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17577577)

  • 21. Identifying siRNA-induced off-targets by microarray analysis.
    Anderson E; Boese Q; Khvorova A; Karpilow J
    Methods Mol Biol; 2008; 442():45-63. PubMed ID: 18369777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Many commonly used siRNAs risk off-target activity.
    Snøve O; Holen T
    Biochem Biophys Res Commun; 2004 Jun; 319(1):256-63. PubMed ID: 15158470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching.
    Jiang P; Wu H; Da Y; Sang F; Wei J; Sun X; Lu Z
    Comput Methods Programs Biomed; 2007 Sep; 87(3):230-8. PubMed ID: 17644215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. siRNA selection criteria--statistical analyses of applicability and significance.
    Bradác I; Svobodová Vareková R; Wacenovsky M; Skrdla M; Plchút M; Polcík M
    Biochem Biophys Res Commun; 2007 Jul; 359(1):83-7. PubMed ID: 17524355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. siRNA and isRNA: two edges of one sword.
    Schlee M; Hornung V; Hartmann G
    Mol Ther; 2006 Oct; 14(4):463-70. PubMed ID: 16877044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
    Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
    FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a genome-wide siRNA library using an artificial neural network.
    Huesken D; Lange J; Mickanin C; Weiler J; Asselbergs F; Warner J; Meloon B; Engel S; Rosenberg A; Cohen D; Labow M; Reinhardt M; Natt F; Hall J
    Nat Biotechnol; 2005 Aug; 23(8):995-1001. PubMed ID: 16025102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The construction and identification of siRNA expression vector against hypoxia inducible factor -1 alpha in vitro].
    He LF; Chen KZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):60-4. PubMed ID: 18289474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting effective siRNA target sequences by using Bayes' theorem.
    Takasaki S
    Comput Biol Chem; 2009 Oct; 33(5):368-72. PubMed ID: 19682951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical modification of siRNA.
    Chernolovskaya EL; Zenkova MA
    Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5.
    Ohrt T; Merkle D; Birkenfeld K; Echeverri CJ; Schwille P
    Nucleic Acids Res; 2006; 34(5):1369-80. PubMed ID: 16522647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
    Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
    Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
    Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
    J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential design rules and enzymatic synthesis of siRNAs.
    Sioud M; Leirdal M
    Methods Mol Biol; 2004; 252():457-69. PubMed ID: 15017071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational models with thermodynamic and composition features improve siRNA design.
    Shabalina SA; Spiridonov AN; Ogurtsov AY
    BMC Bioinformatics; 2006 Feb; 7():65. PubMed ID: 16472402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNA produced by recombinant dicer mediates efficient gene silencing in islet cells.
    Hägerkvist R; Mokhtari D; Myers JW; Tengholm A; Welsh N
    Ann N Y Acad Sci; 2005 Apr; 1040():114-22. PubMed ID: 15891014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small interfering RNA for experimental cancer therapy.
    Tong AW; Zhang YA; Nemunaitis J
    Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing and utilization of siRNAs targeting RNA binding proteins.
    Kim DH; Behlke M; Rossi JJ
    Methods Mol Biol; 2008; 488():367-81. PubMed ID: 18982303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cytokine induction by siRNAs is cell type- and transfection reagent-specific.
    Yoo JW; Hong SW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2006 Sep; 347(4):1053-8. PubMed ID: 16857170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.